Multimodality management of brain metastases in metastatic melanoma patients

References

• Harrison BE, Johnson JL, Clough RW, Halperin EC. Selection of patients with melanoma brain metastases for aggressive treatment. Am. J. Clin. Oncol.26(4), 354–357 (2003).
   Google Scholar
• Amer MH, Al-Sarraf M, Baker LH, Vaitkevicius VK. Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer42(2), 660–668 (1978).
   PubMed Web of Science ®Google Scholar
• Majer M, Jensen RL, Shrieve DC et al. Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastases. Cancer110(6), 1329–1337 (2007).
   PubMed Web of Science ®Google Scholar
• Patel JK, Didolkar MS, Pickren JW, Moore RH. Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am. J. Surg.135(6), 807–810 (1978).
   PubMed Web of Science ®Google Scholar
• Bullard DE, Cox EB, Seigler HF. Central nervous system metastases in malignant melanoma. Neurosurgery8(1), 26–30 (1981).
   Google Scholar
• Budman DR, Camacho E, Wittes RE. The current causes of death in patients with malignant melanoma. Eur. J. Cancer14(4), 327–330 (1978).
   PubMed Web of Science ®Google Scholar
• Sampson JH, Carter JH Jr, Friedman AH, Seigler HF. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J. Neurosurg.88(1), 11–20 (1998).
   PubMed Web of Science ®Google Scholar
• Cattell E, Kelly C, Middleton MR. Brain metastases in melanoma: a European perspective. Semin. Oncol.29(5), 513–517 (2002).
   PubMedGoogle Scholar
• Douglas JG, Margolin K. The treatment of brain metastases from malignant melanoma. Semin. Oncol.29(5), 518–524 (2002).
   PubMed Web of Science ®Google Scholar
• Brega K, Robinson WA, Winston K, Wittenberg W. Surgical treatment of brain metastases in malignant melanoma. Cancer66(10), 2105–2110 (1990).
   Google Scholar
• Zacest AC, Besser M, Stevens G et al. Surgical management of cerebral metastases from melanoma: outcome in 147 patients treated at a single institution over two decades. J. Neurosurg.96(3), 552–558 (2002).
   PubMed Web of Science ®Google Scholar
• Langer CJ, Mehta MP. Current management of brain metastases, with a focus on systemic options. J. Clin. Oncol.23(25), 6207–6219 (2005).
   PubMed Web of Science ®Google Scholar
• Wen PY, Schiff D, Kesari S et al. Medical management of patients with brain tumors. J. Neurooncol.80(3), 313–332 (2006).
   PubMed Web of Science ®Google Scholar
• DeAngelis LM, Mandell LR, Thaler HT et al. The role of postoperative radiotherapy after resection of single brain metastases. Neurosurgery24(6), 798–805 (1989).
   PubMed Web of Science ®Google Scholar
• Patchell RA, Tibbs PA, Regine WF et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA280(17), 1485–1489 (1998).
   PubMed Web of Science ®Google Scholar
• Mintz AH, Kestle J, Rathbone MP et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer78(7), 1470–1476 (1996).
   PubMed Web of Science ®Google Scholar
• Fife KM, Colman MH, Stevens GN et al. Determinants of outcome in melanoma patients with cerebral metastases. J. Clin. Oncol.22(7), 1293–1300 (2004).
   PubMed Web of Science ®Google Scholar
• Meier S, Baumert BG, Maier T et al. Survival and prognostic factors in patients with brain metastases from malignant melanoma. Onkologie27(2), 145–149 (2004).
   PubMedGoogle Scholar
• Broadbent AM, Hruby G, Tin MM, Jackson M, Firth I. Survival following whole brain radiation treatment for cerebral metastases: an audit of 474 patients. Radiother. Oncol.71(3), 259–265 (2004).
   PubMedGoogle Scholar
• Lagerwaard FJ, Levendag PC, Nowak PJ et al. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int. J. Radiat. Oncol. Biol. Phys.43(4), 795–803 (1999).
   PubMed Web of Science ®Google Scholar
• Gaspar L, Scott C, Rotman M et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int. J. Radiat. Oncol. Biol. Phys.37(4), 745–751 (1997).
   PubMed Web of Science ®Google Scholar
• Agarwala SS, Kirkwood JM, Gore M et al. Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a Phase II study. J. Clin. Oncol.22(11), 2101–2107 (2004).
   PubMed Web of Science ®Google Scholar
• Bafaloukos D, Tsoutsos D, Fountzilas G et al. The effect of temozolomide-based chemotherapy in patients with cerebral metastases from melanoma. Melanoma Res.14(4), 289–294 (2004).
   PubMed Web of Science ®Google Scholar
• Jacquillat C, Khayat D, Banzet P et al. Final report of the French multicenter Phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases. Cancer66(9), 1873–1878 (1990).
   PubMed Web of Science ®Google Scholar
• Stupp R, Mason WP, van den Bent MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med.352(10), 987–996 (2005).
   PubMed Web of Science ®Google Scholar
• Margolin K, Atkins B, Thompson A et al. Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a Phase II trial of the Cytokine Working Group. J. Cancer Res. Clin. Oncol.128(4), 214–218 (2002).
   PubMed Web of Science ®Google Scholar
• Hofmann M, Kiecker F, Wurm R et al. Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases. J. Neurooncol.76(1), 59–64 (2006).
   PubMed Web of Science ®Google Scholar
• Grob JJ, Regis J, Laurans R et al. Radiosurgery without whole brain radiotherapy in melanoma brain metastases. Club de Cancérologie Cutanée. Eur. J. Cancer34(8), 1187–1192 (1998).
   PubMedGoogle Scholar
• Noel G, Simon JM, Valery CA et al. Linac radiosurgery for brain metastasis of melanoma. Stereotact. Funct. Neurosurg.79(3–4), 245–255 (2002).
   Google Scholar
• Gonzalez-Martinez J, Hernandez L, Zamorano L et al. Gamma knife radiosurgery for intracranial metastatic melanoma: a 6-year experience. J. Neurosurg.97(Suppl. 5), 494–498 (2002).
   PubMed Web of Science ®Google Scholar
• Herfarth KK, Izwekowa O, Thilmann C et al. Linac-based radiosurgery of cerebral melanoma metastases. Analysis of 122 metastases treated in 64 patients. Strahlenther. Onkol.179(6), 366–371 (2003).
   PubMed Web of Science ®Google Scholar
• Selek U, Chang EL, Hassenbusch SJ III et al. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int. J. Radiat. Oncol. Biol. Phys.59(4), 1097–1106 (2004).
   PubMed Web of Science ®Google Scholar
• Radbill AE, Fiveash JF, Falkenberg ET et al. Initial treatment of melanoma brain metastases using gamma knife radiosurgery: an evaluation of efficacy and toxicity. Cancer101(4), 825–833 (2004).
   PubMed Web of Science ®Google Scholar
• Koc M, McGregor J, Grecula J et al. Gamma Knife radiosurgery for intracranial metastatic melanoma: an analysis of survival and prognostic factors. J. Neurooncol.71(3), 307–313 (2005).
   Google Scholar
• Mindermann T. Tumor recurrence and survival following gamma knife surgery for brain metastases. J. Neurosurg.102(Suppl.), 287–288 (2005).
   Google Scholar
• Wowra B, Muacevic A, Jess-Hempen A, Tonn JC. Safety and efficacy of outpatient gamma knife radiosurgery for multiple cerebral metastases. Expert Rev. Neurotherapeutics4(4), 673–679 (2004).
   PubMedGoogle Scholar
• Stone A, Cooper J, Koenig KL, Golfinos JG, Oratz R. A comparison of survival rates for treatment of melanoma metastatic to the brain. Cancer Invest.22(4), 492–497 (2004).
   PubMed Web of Science ®Google Scholar
• Ulm AJ, Friedman WA, Bova FJ et al. Linear accelerator radiosurgery in the treatment of brain metastases. Neurosurgery55(5), 1076–1085 (2004).
   Google Scholar
• Gaudy-Marqueste C, Regis JM, Muracciole X et al. Gamma-Knife radiosurgery in the management of melanoma patients with brain metastases: a series of 106 patients without whole-brain radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.65(3), 809–816 (2006).
   PubMed Web of Science ®Google Scholar
• Bhatnagar AK, Flickinger JC, Kondziolka D, Lunsford LD. Stereotactic radiosurgery for four or more intracranial metastases. Int. J. Radiat. Oncol. Biol. Phys.64(3), 898–903 (2006).
   PubMed Web of Science ®Google Scholar
• Manon R, O’Neill A, Knisely J et al. Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E6397). J. Clin. Oncol.23(34), 8870–8876 (2005).
   PubMed Web of Science ®Google Scholar
• Kondziolka D, Martin JJ, Flickinger JC et al. Long-term survivors after gamma knife radiosurgery for brain metastases. Cancer104(12), 2784–2791 (2005).
   PubMed Web of Science ®Google Scholar
• Jawahar A, Shaya M, Campbell P et al. Role of stereotactic radiosurgery as a primary treatment option in the management of newly diagnosed multiple (3–6) intracranial metastases. Surg. Neurol.64(3), 207–212 (2005).
   Google Scholar
• DiLuna ML, King JT Jr, Knisely JP, Chiang VL. Prognostic factors for survival after stereotactic radiosurgery vary with the number of cerebral metastases. Cancer109(1), 135–145 (2007).
   PubMed Web of Science ®Google Scholar
• Rades D, Bohlen G, Pluemer A et al. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients. Cancer109(12), 2515–2521 (2007).
   PubMed Web of Science ®Google Scholar
• Samlowski WE, Watson GA, Wang M et al. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS). Cancer109, 1855–1862 (2007).
   PubMed Web of Science ®Google Scholar
• Petrovich Z, Yu C, Giannotta SL, O’Day S, Apuzzo ML. Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery. J. Neurosurg.97(Suppl. 5), 499–506 (2002).
   PubMed Web of Science ®Google Scholar
• Sawrie SM, Guthrie BL, Spencer SA et al. Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery alone. Int. J. Radiat. Oncol. Biol. Phys. (2007) (Epub ahead of print).
   Google Scholar
• Andrews DW, Scott CB, Sperduto PW et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial. Lancet363(9422), 1665–1672 (2004).
   PubMed Web of Science ®Google Scholar
• Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int. J. Radiat. Oncol. Biol. Phys.45(2), 427–434 (1999).
   PubMed Web of Science ®Google Scholar
• Aoyama H, Shirato H, Tago M et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA295(21), 2483–2491 (2006).
   PubMed Web of Science ®Google Scholar
• Boasberg PD, O’Day SJ, Kristedja TS et al. Biochemotherapy for metastatic melanoma with limited central nervous system involvement. Oncology64(4), 328–335 (2003).
   PubMed Web of Science ®Google Scholar
• Panagiotou IE, Brountzos EN, Kelekis DA, Papathanasiou MA, Bafaloukos DI. Cerebral metastases of malignant melanoma: contemporary treatment modalities and survival outcome. Neoplasma52(2), 150–158 (2005).
   Google Scholar
• Majer M, Samlowski WE. Management of metastatic melanoma patients with brain metastases. Curr. Oncol. Rep.9(5), 411–416 (2007).
   PubMedGoogle Scholar
• Mori Y, Kondziolka D, Flickinger JC et al. Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival. Int. J. Radiat. Oncol. Biol. Phys.42(3), 581–589 (1998).
   PubMed Web of Science ®Google Scholar